Development of diabetes after gatifloxacin therapy.
Stading
Julie A
JA
School of Pharmacy Practice, Creighton University, Omaha, NE 68178, USA. jstading@ad.creighton.edu
Chock
Alan W Y
AW
Skrabal
Maryann Z
MZ
Faulkner
Michele A
MA
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose; D002481:Cellulitis / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D024841:Fluoroquinolones / Q000009:adverse effects* / Q000627:therapeutic use; D000077734:Gatifloxacin; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D024841:Fluoroquinolones; D000077734:Gatifloxacin